Does the presence of right ventricular dysfunction or elevated cardiac biomarkers predict early mortality in patients with low-risk acute pulmonary embolism?
The presence of RV dysfunction or elevated cardiac biomarkers identifies a higher risk of early mortality in acute pulmonary embolism patients who otherwise appear to be at low clinical risk.
In low-risk patients with acute PE, the presence of RV dysfunction on admission was associated with early mortality. Our results may have implications for the management of patients who appear at low risk based on clinical criteria alone, but present with RV dysfunction as indicated by imaging findings or laboratory markers.
Barco et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: